OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,650 | -57.9% | 22,500 | -30.8% | 0.01% | -57.9% |
| Q2 2023 | $167,700 | -84.7% | 32,500 | -84.3% | 0.02% | -86.0% |
| Q1 2023 | $1,094,178 | +43.8% | 207,624 | -23.3% | 0.14% | +33.3% |
| Q4 2022 | $760,645 | -49.6% | 270,692 | -25.6% | 0.10% | -50.2% |
| Q3 2022 | $1,510,000 | +183.3% | 363,844 | +174.3% | 0.20% | +225.4% |
| Q2 2022 | $533,000 | -13.2% | 132,654 | +80.0% | 0.06% | -25.0% |
| Q2 2020 | $614,000 | +314.9% | 73,678 | +145.6% | 0.08% | +250.0% |
| Q1 2020 | $148,000 | -16.9% | 30,000 | -33.3% | 0.02% | +33.3% |
| Q4 2019 | $178,000 | – | 45,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |